Colonic (poly)phenol metabolites as promising tools to control inflammation and prevent cardiovascular disease
European Atherosclerosis Journal · 30.04.2026 · 5 (1) · 22
DOI: 10.56095/eaj.v5i1.129 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Atherosclerosis Journal, online erschienen am 30.04.2026. Verfasst von Paola Bonicco und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
Chronic inflammation underlies numerous diseases, including atherosclerosis. The identification of anti-inflammatory agents, particularly from dietary sources, is of great interest for the development of functional products targeting early stages of chronic inflammatory conditions. This study investigated the in vitro anti-inflammatory activity of chiral phenyl-γ-valerolactones, the main colonic metabolites of flavan-3-ols.
Methods
Human dermal fibroblasts were treated with 10 phenyl-γ-valerolactones (1 μM) for 48 hours. Compounds included pure enantiomers and methylated or sulfated derivatives, tested at concentrations representative of plasma levels following dietary intake. During the first 24 hours, cells were treated under basal conditions; during the second 24 hours, treatments were repeated in the presence or absence of lipopolysaccharide (LPS, 1 μg/mL). Cytotoxicity was assessed by MTT and lactate dehydrogenase assays (LDH). Anti-inflammatory activity was evaluated by measuring IL-6 and IL-8 secretion using ELISA, with data normalized to protein content (bicinchoninic acid assay). To investigate the underlying mechanism of action, NF-κB activation was assessed by western blot analysis of p65 expression, normalized to β-actin. A 24-hour pharmacokinetic study was conducted to evaluate compound biotransformation and to characterize metabolic products, monitoring 31 phenyl-γ-valerolactones.
Results
None of the tested compounds induced cytotoxicity. (4R)-5-(4ʹ-hydroxyphenyl)-γ-valerolactone (R-CC01) reduced IL-6 and IL-8 secretion by 76% (p
Zitieren
APA
Bonicco, P., Mattina, B., Curti, C., Giorgio, C., Tognolini, M., Favari, C., Mena, P., Ronda, N., & Zanotti, I. (2026). Colonic (poly)phenol metabolites as promising tools to control inflammation and prevent cardiovascular disease. European Atherosclerosis Journal, 5(1), 22. https://doi.org/10.56095/eaj.v5i1.129
Vancouver
Bonicco P, Mattina B, Curti C, Giorgio C, Tognolini M, Favari C, et al. Colonic (poly)phenol metabolites as promising tools to control inflammation and prevent cardiovascular disease. European Atherosclerosis Journal. 2026;5(1):22. doi:10.56095/eaj.v5i1.129
BibTeX
@article{Bonicco2026,
author = {Bonicco, Paola and Mattina, Beatrice and Curti, Claudio and Giorgio, Carmine and Tognolini, Massimiliano and Favari, Claudia and Mena, Pedro and Ronda, Nicoletta and Zanotti, Ilaria},
title = {Colonic (poly)phenol metabolites as promising tools to control inflammation and prevent cardiovascular disease},
journal = {European Atherosclerosis Journal},
year = {2026},
volume = {5},
number = {1},
pages = {22},
doi = {10.56095/eaj.v5i1.129}
}
EUVIMED